SHH and neoplasm: Consistent with these results, our analysis of RNA-seq expression profiles confirmed that the gene signature related with the luminal status is negatively enriched in the tumors expressing shRNA for Shh, whereas tumor expressing control shRNA showed standard signature of luminal-like subtype (Figure 5D and Figure 5—figure supplement 1F).